Efficacy and tolerability of rifaximin, a nonabsorbed oral antibiotic, in the treatment of active Crohn's disease: results of an open-label study

Shafran, Ira; Johnson, Lorin K; Hamm, Lynne; Murdock, Robert H
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS250
Academic Journal
An abstract of the article concerning rifaximin treatment of active crohn's disease is presented.


Related Articles

  • Crohn's disease: Choosing the right therapy. Frank, Michael S.; Ott, David J. // Patient Care;10/30/1993, Vol. 27 Issue 17, p52 

    Features several therapeutic drugs and medications for the treatment of Crohn's disease. Sulfasalazine; Pentasa; Oral mesalamine agents; Corticosteroids; Antidiarrheals; Antibiotics; Immunosuppressive drugs; Mercaptopurine; Methotrexate; Cyclosporine; Nutritional support. INSETS: The outlook...

  • Anti-Interleukin-6 Therapy for Crohn's Disease. Ito, H. // Current Pharmaceutical Design;Feb2003, Vol. 9 Issue 4, p295 

    Proinflammatory cytokines have been demonstrated to play a crucial role in the pathogenesis and physiopathology of various chronic inflammatory conditions including Crohn's disease (CD). Among these cytokines, interleukin-6 (IL-6) must be especially important because increased serum...

  • Methotrexate for the Treatment of Crohn's Disease. Feagan, Brian G.; Rochon, James; Fedorak, Richard N.; Irvine, E. Jan; Wild, Gary; Sutherland, Lloyd; Steinhart, A. Hillary; Greenberg, Gordon R.; Gillies, Richard; Hopkins, Marybeth; Hanauer, Stephen B.; McDonald, John W.D. // New England Journal of Medicine;2/2/95, Vol. 332 Issue 5, p292 

    Background: Although corticosteroids are highly effective in improving symptoms of Crohn's disease, they may have substantial toxicity. In some patients, attempts to discontinue corticosteroids are unsuccessful. Methods: We conducted a double-blind, placebo-controlled multicenter study of weekly...

  • Methotrexate for Chronic Diseases in Adults. Weinblatt, Michael E. // New England Journal of Medicine;2/2/95, Vol. 332 Issue 5, p330 

    Comments on an article in the February 2, 1995 issue of the `New England Journal of Medicine,' by Feagan and colleagues. The report on a study which found that in a 16-week double-blind trial, intramuscular methotrexate was more effective than placebo in improving symptoms and reducing...

  • A Comparison of Budesonide and Mesalamine for Active Crohn's Disease.  // New England Journal of Medicine;11/29/2001, Vol. 345 Issue 22, p1652 

    A correction to the article "A Comparison of Budesonide and Mesalamine for Active Crohn's Disease," that was published in the August 6, 1998 issue of the "New England Journal of Medicine" is presented.

  • Maintenance Therapy with Certolizumab Pegol for Crohn's Disease.  // New England Journal of Medicine;9/27/2007, Vol. 357 Issue 13, p1357 

    This article presents a correction to the article "Maintenance Therapy with Certolizumab Pegol for Crohn's Disease," in the July 19, 2007 issue.

  • Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data. Rubin, D. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 3, p122 

    A review of the article "Response to biologic therapy in Crohn's disease is improved with early treatment: An analysis of health claims data," by D. T. Rubin, O. Uluscu, and R. Sederman, which appeared in the periodical "Inflammatory Bowel Diseases" in the 2012 issue is presented.

  • New Relief for Crohn's Disease. Harrar, Sari; Metcalf, Eric // Prevention;Mar2002, Vol. 54 Issue 3, p155 

    Reports that the steroid drug budesonide is effective in treating Crohn's disease flare-ups and has fewer side effects than prednisone, the conventional therapy.

  • Continuing Education Case Study Quiz.  // Hospital Pharmacy;Dec2008, Vol. 43 Issue 12, p1008 

    Goal--The goal of this program is to educate the reader about the use of certolizumab in the treatment of Crohn disease. Objectives--At the completion of this program, the reader will be able to: 1. Describe the pharmacology and pharmacokinetics of certolizumab. 2. Discuss the risks associated...

  • Cat's claw. Foster, Steven // Better Nutrition;May96, Vol. 58 Issue 5, p50 

    Reports on the medicinal use of cat's claw as it relates to the treatment of Crohn's disease. Its origin; Discription of cat's claw; Other uses of cat's claw; Information on U. guianensis and U. tomentosa; What the book `Witch Doctor's Apprentic reveals about cat's claw; Hunting for Medicinal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics